| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003881A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 01/28/1999 | WO1999003880A1 Nociceptin analogues |
| 01/28/1999 | WO1999003877A1 Methods of unfolding proteins using metal complexes |
| 01/28/1999 | WO1999003875A1 Nucleotide sequence of the nucleocapsid gene of oropouche virus |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1999003506A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 01/28/1999 | WO1999003501A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 01/28/1999 | WO1999003494A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase |
| 01/28/1999 | WO1999003492A1 Antiviral and antitumor agents |
| 01/28/1999 | WO1999003490A1 Proteins and peptides for contraceptive vaccines and fertility diagnosis |
| 01/28/1999 | WO1999003489A2 Methods and compositions for regulating nuclear trafficking of proteins |
| 01/28/1999 | WO1999003488A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | WO1999003484A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | WO1999003452A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | WO1999003352A1 Sublancin lantibiotic produced by bacillus subtilis 168 |
| 01/28/1999 | WO1999003336A1 Transgenic mammals |
| 01/28/1999 | WO1999003328A1 TOXIN GENES FROM THE BACTERIA XENORHABDUS NEMATOPHILUS AND $i(PHOTORHABDUS LUMINESCENS) |
| 01/28/1999 | WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 01/28/1999 | WO1998048032A3 POLY-(α-L-ASPARTIC ACID), POLY-(α-L-GLUTAMIC ACID) AND COPOLYMERS OF L-ASP AND L-GLU, METHOD FOR THEIR PRODUCTION AND THEIR USE |
| 01/28/1999 | WO1998046759A3 Plants with controlled side-shoot formation and/or controlled abscission area formation |
| 01/28/1999 | WO1998046637A3 Herpes simplex virus us3 and icp4 as inhibitors of apoptosis |
| 01/28/1999 | WO1998046636A3 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 01/28/1999 | WO1998046632A3 Inhibitors for urokinase receptor |
| 01/28/1999 | WO1998038324A3 Chimeric cell-surface receptors that undergo antigen-induced association |
| 01/28/1999 | WO1998027932A3 Cerebellum and embryo specific protein |
| 01/28/1999 | DE19731741A1 Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe Conjugate to distinguish between diseased and healthy tissue |
| 01/28/1999 | DE19720165A1 Production of polymeric compounds with nucleo-base substituent(s) |
| 01/28/1999 | CA2298066A1 Methods and compositions for regulating nuclear trafficking of proteins |
| 01/28/1999 | CA2297374A1 Modified immunogenic pneumolysin, compositions and their use as vaccines |
| 01/28/1999 | CA2297362A1 Methods of unfolding proteins using metal complexes |
| 01/28/1999 | CA2297105A1 Transgenic mammals |
| 01/28/1999 | CA2297103A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | CA2297072A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 01/28/1999 | CA2296815A1 64 human secreted proteins |
| 01/28/1999 | CA2296796A1 Special virus dna fragments and their use as promoter |
| 01/28/1999 | CA2296770A1 Derivatives of growth hormone and related proteins |
| 01/28/1999 | CA2296762A1 Interleukin-20 |
| 01/28/1999 | CA2296761A1 Process of producing transgenic plants in which flowering is inhibited, and dna sequences used in said process |
| 01/28/1999 | CA2296738A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | CA2296700A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | CA2296689A1 Increasing production of proteins in gram-positive microorganisms |
| 01/28/1999 | CA2296666A1 T-cell receptor beta-like protein |
| 01/28/1999 | CA2296620A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | CA2296530A1 Adipocyte-specific protein homologs |
| 01/28/1999 | CA2296508A1 Structure of the ankyrin binding domain of a alpha-na,k-atpase |
| 01/28/1999 | CA2296447A1 Human atp-binding cassette transport protein |
| 01/28/1999 | CA2296445A1 Induction of male sterility in plants by expression of high levels of avidin |
| 01/28/1999 | CA2296442A1 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | CA2296419A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 01/28/1999 | CA2296416A1 Assays therapeutic methods and means |
| 01/28/1999 | CA2296089A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2295719A1 Trail receptor |
| 01/28/1999 | CA2295552A1 Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 01/28/1999 | CA2294518A1 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/27/1999 | EP0893691A1 Methods for diagnosis and therapy of autoimmunedisease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 01/27/1999 | EP0893505A2 Novel glucose kinase |
| 01/27/1999 | EP0893504A1 Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893502A2 GreA from Staphylococcus aureus |
| 01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
| 01/27/1999 | EP0893500A2 BmrU gene from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893449A1 Antitumor substance extracted from hen-of-the-woods |
| 01/27/1999 | EP0893439A1 Polypeptides modified by carbonates of polyalkylene oxide polymers |
| 01/27/1999 | EP0892854A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892813A1 Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs |
| 01/27/1999 | EP0892812A2 Agonist peptide dimers |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 01/27/1999 | EP0804066A4 Transgenic plants with altered senescence characteristics |
| 01/27/1999 | EP0765125B1 Process for the fractionation of whey constituents |
| 01/27/1999 | EP0670846B1 A process for the purification of natural pulmonary surfactant material using supercritical fluids |
| 01/27/1999 | EP0658198B1 Multicistronic expression units and their use |
| 01/27/1999 | EP0602032B1 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay |
| 01/27/1999 | EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/27/1999 | EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |
| 01/27/1999 | CN1206458A Ceramic packing with channels for thermal and catalytic beds |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/27/1999 | CN1041831C Neurotrophic factors having altered receptor binding specificities |
| 01/26/1999 | US5864488 Three dimensional glycoprotein hormone structure representation using a computer |
| 01/26/1999 | US5864029 Anti-sickling hemoglobin |
| 01/26/1999 | US5864027 HIV envelope polypeptides |
| 01/26/1999 | US5864026 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 01/26/1999 | US5864021 Method and apparatus for the production of TGF-β and purified TGF-β compositions |
| 01/26/1999 | US5864020 A monoclonal antibody specifically binds to a hepatoma transmembrane kinase receptor ligand having selective amino acid sequence |
| 01/26/1999 | US5864015 Hodgkin's disease associated molecules |
| 01/26/1999 | US5864014 Membrane-associate protein which is present on the surface of intestinal epithelia cells; acts as a receptor for the zonula occludens toxin of vibrio cholera, and is related to the modulation of intestinal tight junctions |
| 01/26/1999 | US5864013 Materials for the production of nanometer structures and use thereof |
| 01/26/1999 | US5864012 Oligopeptides as antitumor agents |